vaginal bleeding; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority. the reporter is the patient. regulatory number: gb-ra-webcovid-202202152235214010-r8klh (ra). other case identifier(s): gb-ra-adr 26608461 (ra). a 35 year-old female patient received bnt162b2 (comirnaty) (batch/lot number: unknown) as dose 2, single for covid-19 immunisation. relevant medical history included: "covid-19", start date: 16jul2021 (unspecified if ongoing). the patient's concomitant medications were not reported. vaccination history included: covid-19 vaccine (dose 1; manufacturer unknown), for covid-19 immunisation. the following information was reported: vaginal haemorrhage (medically significant) with onset 01dec2021, outcome "recovered" (01feb2022), described as "vaginal bleeding". the event "vaginal bleeding" was evaluated at the physician office visit. patient had not had symptoms associated with covid-19. since second dose patient had unexplained vaginal bleeding, mild. patient had never had an irregularity for 20 years. doctor had ruled out any known causes. second cycle since jab, unexplained bleeding had stopped. patient had not tested positive for covid-19 since having the vaccine. patient was not enrolled in clinical trial. the patient underwent the following laboratory tests and procedures: laboratory test: (unspecified date) unknown result, notes: swabs (unspecified); sars-cov-2 test: (16jul2021) yes - positive covid-19 test. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

test name: lab test; result unstructured data: test result:unknown result; comments: swabs (unspecified); test date: 20210716; test name: covid-19 virus test; result unstructured data: test result:yes - positive covid-19 test

na

na